Financhill
Back

Kymera Therapeutics Vs. Avidity Biosciences Industry Stock Comparison

Sell
39

KYMR
Kymera Therapeutics

Last Price:
$40.66
Seasonality Move:
2.79%
Sell
13

RNA
Avidity Biosciences

Last Price:
$31.84
Seasonality Move:
38.33%
Sell
39
Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $40.64. The Score for KYMR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • KYMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
13
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $31.82. The Score for RNA is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $40.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $31.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing slight buying pressure.

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.61 Sell
Relative Strength Index (14 RSI): 40.07 Sell
Chaikin Money Flow: 1023886 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.59 - 46.41) Sell
Bollinger Bands (100): (42.92 - 48.78) Sell

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.35 Sell
Relative Strength Index (14 RSI): 31.67 Sell
Chaikin Money Flow: 247445 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.75 - 42.97) Sell
Bollinger Bands (100): (38.89 - 47.21) Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.68 Sell
20-day SMA: 44.26 Sell
50-day SMA: 45.89 Sell
200-day SMA: 41.31 Sell
8-day EMA: 41.51 Sell
20-day EMA: 43.39 Sell
50-day EMA: 44.87 Sell
200-day EMA: 41.09 Sell

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.7 Sell
20-day SMA: 37.3 Sell
50-day SMA: 42.36 Sell
200-day SMA: 37.02 Sell
8-day EMA: 32.94 Sell
20-day EMA: 36.33 Sell
50-day EMA: 40.15 Sell
200-day EMA: 36.08 Sell

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.37 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.26 per share.

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):